Seattle Genetics Announces Pivotal Results in Lymphoma Drug Trial

Image via WikipediaLymphoma news from Seattle Genetics hitting the web. This company is really making strides with Non-Hodgkin's Lymphoma drug Brentuximab. This drug is partnered with Takeda Oncology's Millennium. Takeda is a global pharmaceutical firm who specializes in Clinical Trials and marketing on a global scale. Brentuximab elicited 75% response rate in patients that had already rejected other cancer drugs, which is common.

Comprehensive List of Drug Approvals From 2009

Image by boodoo via Flickr I found a nice list of all the drugs approved in 2009 and their respectable companies.

Those of note were Glaxo SmithKline (GSK) with HPV vaccine, H1N1, seasonal flu vaccine, renal carcinoma, and lymphocyte leukemia.

Novartis (NVS) for H1N1, seasonal flu vaccine, MS, malaria, and schizophrenia.

Schering-Plough, now Merck (MRK) , for schizophrenia. Schering was bought out for their extensive drug pipeline of numerous upcoming drugs.

Sanofi-Aventis (SNY) had an antiarrhythmic drug, along with another flu vaccine for elderly patients. Sanofi is getting snuffed out with the Genzyme takeover bid but the bidding could still continue.

Others included Takeda Pharmaceuticals (TKPHF), Cypress Biosciences/Forest Labs, Allos Therapeutics, Lilly/Daiichi Sankyo, Gloucester Pharmaceuticals, and Theravance.